Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Ibuprofen/Fexofenadine for Dark Circles
NCT01172522Phase 2Completed
- Start
- Sep 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ibuprofen and fexofenadine in periorbital hyperpigmentation (POH) and periorbital edema (2 arms). Primary endpoint: Number of Participants Who Showed Improvement in Under Eye Swelling and Dark Circles Relative to Baseline Per Intervention at Day 37. Started Sep 2010; status: completed.
02
Drugs
ibuprofenfexofenadine
03
Conditions
periorbital hyperpigmentation (POH)periorbital edema
Beyond the preview
Go deeper on NCT01172522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01172522.